Portfolio company
Avidicure
Germany
Raised
Undisclosed
Latest stage
Seed
Rounds recorded
1 · 1 undisclosed
Backed by
2 investors
Sectors
About
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
SourceFunding history · 1
Similar companies
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
Cytospire Therapeutics
This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.
VelaVigo
This biotechnology company develops multi-specific antibodies and antibody-drug conjugates for patients with cancer and autoimmune diseases.
Cytospire
This biotechnology company develops multispecific immune cell engager antibodies to treat patients with solid and liquid tumours.
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
Pionyr Immunotherapeutics
This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.
Callio Therapeutics
The company develops multi-payload antibody-drug conjugates to treat cancer patients.
Adcytherix
This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.
